Adaptive Biotechnologies Corp (ADPT) › Operating IncomeAdaptive Biotechnologies Corp (ADPT) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2017: -$44.48M2018: -$49.76M2019: -$78.39M2020: -$152.82M2021: -$208.97M2022: -$200.19M2023: -$227.03M2024: -$162.55M2025: -$57.12M-$57.12M2017Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$57.12M+64.9%2024-$162.55M+28.4%2023-$227.03M-13.4%2022-$200.19M+4.2%2021-$208.97M-36.7%2020-$152.82M-94.9%2019-$78.39M-57.6%2018-$49.76M-11.9%2017-$44.48M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share